Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Population Growth

Population Growth

Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.However, realistic environmental conditions limit the number of...

Theories of Dissolution: The Danckwerts' Model and Interfacial Barrier Model

Theories of Dissolution: The Danckwerts' Model and Interfacial Barrier Model

Various dissolution theories provide insight into the factors that influence the dissolution rate. Danckwerts' Model suggests that turbulence, rather than a stagnant layer, characterizes the dissolution medium at the solid-liquid interface. In this model, the agitated solvent contains macroscopic packets that move to the interface via eddy currents, facilitating the absorption and delivery of the drug to the bulk solution. The regular replenishment of solvent packets maintains the concentration...

Modeling with Differential Equations

Modeling with Differential Equations

Population dynamics can be described mathematically by considering the population size P(t) as a function of time. The rate of change of the population is then represented by the derivative of P(t). A simple assumption is that the rate of growth is proportional to the size of the population itself. This leads to an exponential growth model, where the population increases rapidly without bound. While this is a useful first approximation, it does not reflect realistic long-term...

Theories of Dissolution: Diffusion Layer Model

Theories of Dissolution: Diffusion Layer Model

Dissolution, the process by which drug particles dissolve in a solvent, is explained by the diffusion layer model, a theoretical framework that simulates the absorption of oral drugs and allows us to analyze experimental data.
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Non-linear IV pharmacokinetics of the ATR inhibitor berzosertib (M6620) in mice.

Cancer chemotherapy and pharmacology·2024

Same author

An in-silico modeling approach to separate exogenous and endogenous plasma insulin appearance, with application to inhaled insulin.

Scientific reports·2024

Same author

Long-term forecasting of a motor outcome following rehabilitation in chronic stroke via a hierarchical bayesian dynamic model.

Journal of neuroengineering and rehabilitation·2023

Same author

Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development.

Frontiers in pharmacology·2023

Same author

Monoclonal Antibody Pharmacokinetics in Cynomolgus Monkeys Following Subcutaneous Administration: Physiologically Based Model Predictions from Physiochemical Properties.

The AAPS journal·2022

Same author

Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin.

Pharmaceutical research·2022

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Synthesis of Cyclic Polymers and Characterization of Their Diffusive Motion in the Melt State at the Single Molecule Level

Synthesis of Cyclic Polymers and Characterization of Their Diffusive Motion in the Melt State at the Single Molecule Level

Published on: September 26, 2016

A note on population analysis of dissolution-absorption models using the inverse Gaussian function.

Jian Wang¹, Michael Weiss, David Z D'Argenio

¹Department of Biomedical Engineering, University of Southern California, 1042 Downey Way, DRB 140, Los Angeles, CA 90089, USA.

Journal of Clinical Pharmacology

|March 25, 2008

Summary

This summary is machine-generated.

This study enhances oral drug absorption modeling by integrating first-order kinetics with the inverse Gaussian function. This improved pharmacokinetic analysis for extended-release drugs and patient-specific liver disease kinetics.

More Related Videos

Controlled Synthesis and Fluorescence Tracking of Highly Uniform Poly(N-isopropylacrylamide) Microgels

Controlled Synthesis and Fluorescence Tracking of Highly Uniform Poly(N-isopropylacrylamide) Microgels

Published on: September 8, 2016

An Introduction to Processing, Fitting, and Interpreting Transient Absorption Data

An Introduction to Processing, Fitting, and Interpreting Transient Absorption Data

Published on: February 16, 2024

Related Experiment Videos

Last Updated: Jul 6, 2026

Synthesis of Cyclic Polymers and Characterization of Their Diffusive Motion in the Melt State at the Single Molecule Level

Synthesis of Cyclic Polymers and Characterization of Their Diffusive Motion in the Melt State at the Single Molecule Level

Published on: September 26, 2016

Controlled Synthesis and Fluorescence Tracking of Highly Uniform Poly(N-isopropylacrylamide) Microgels

Controlled Synthesis and Fluorescence Tracking of Highly Uniform Poly(N-isopropylacrylamide) Microgels

Published on: September 8, 2016

An Introduction to Processing, Fitting, and Interpreting Transient Absorption Data

An Introduction to Processing, Fitting, and Interpreting Transient Absorption Data

Published on: February 16, 2024

Area of Science:

Pharmacokinetics and Pharmacodynamics
Mathematical Modeling in Pharmacology
Drug Absorption and Metabolism

Background:

Conventional absorption models struggle with oral drug plasma concentration-time profiles.
Empirical functions like the inverse Gaussian model offer improved descriptions.
Need for enhanced models to capture complex absorption processes.

Purpose of the Study:

To extend the inverse Gaussian absorption model by incorporating a first-order absorption process.
To demonstrate population analysis using maximum likelihood estimation (EM algorithm).
To validate the enhanced model with real-world pharmacokinetic data.

Main Methods:

Population analysis utilizing maximum likelihood estimation via the Expectation-Maximization (EM) algorithm.
Implementation of the enhanced model in ADAPT 5 software.
Application to bioavailability data of extended-release formulations and trapidil kinetics in liver disease patients.

Main Results:

The enhanced inverse Gaussian model, including first-order absorption, improved pharmacokinetic profile fits in both tested examples.
Mean dissolution times estimated in vivo and in vitro using the inverse Gaussian function showed good agreement for extended-release formulations.
High interindividual variability in absorption/dissolution parameters was observed for trapidil in liver disease patients.

Conclusions:

The inverse Gaussian function effectively models in vivo dissolution processes.
Integrating a first-order absorption process enhances the accuracy of oral drug absorption modeling.
The developed model provides a robust tool for analyzing complex pharmacokinetic data, including population variability.